Hugo Prazeres

2PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 05, 2021
Resistance to endocrine therapy in HR + and/or HER2 + breast cancer: the most promising predictive biomarkers.

Flávia Miranda, Hugo Prazeres, Fernando Mendes

|Aug 18, 2018
Liposomal therapies in oncology: does one size fit all?

Isabel Sousa, Filipa Rodrigues, Hugo Prazeres

Pageof 1